What will be the role of I-123 MIBG in improving the outcome of medically treated heart failure patients?

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of nuclear cardiology 2012-12, Vol.19 (6), p.1198-1205
Hauptverfasser:	Waqar, Fahad, Dunlap, Stephanie H., Gerson, Myron C.
Format:	Artikel
Sprache:	eng
Schlagworte:	3-Iodobenzylguanidine Angiotensin Receptor Antagonists - therapeutic use Angiotensin-Converting Enzyme Inhibitors - therapeutic use Baseline Systolic Blood Pressure Candesartan Cardiology Carvedilol Drug Therapy, Combination Heart Failure - diagnostic imaging Heart Failure - drug therapy Heart Rate Variability Humans Imaging Left Ventricular Ejection Fraction Medicine Medicine & Public Health Meta-Analysis as Topic Mineralocorticoid Receptor Antagonists - therapeutic use Nuclear Medicine Radiology Radiopharmaceuticals Randomized Controlled Trials as Topic Review Article Tomography, Emission-Computed, Single-Photon - methods Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!